The Clinical Practice Guideline for Off-label Drug Use in Ophthalmology in China: a executive summary

doi:10.3969/j.issn.1672-3384.2022.09.006

LI Guang-yao, WANG Ning-li, ZHANG Yu, WEI Wen-bin, LU Hai, ZHAI Suo-di, ZHANG Chao

Clinical Medication Journal ›› 2022, Vol. 20 ›› Issue (9) : 28-36.

PDF(539 KB)

Clinical Medication Journal ›› 2022, Vol. 20 ›› Issue (9) : 28-36. DOI: 10.3969/j.issn.1672-3384.2022.09.006

Drug Therapy of Eye Diseases

The Clinical Practice Guideline for Off-label Drug Use in Ophthalmology in China: a executive summary

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 20(9): 28-36 https://doi.org/10.3969/j.issn.1672-3384.2022.09.006

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(539 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2022-07-10	2022-09-28
Issue Date
2022-09-28

Please choose a citation manager

Content to export